Research programme: RNA therapeutics - Suono-Bio
Alternative Names: Unformulated RNA therapeutics - Suono-BioLatest Information Update: 28 Feb 2026
At a glance
- Originator Suono Bio
- Class RNA
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gastrointestinal disorders
Most Recent Events
- 28 Feb 2026 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in USA (Intradermal)
- 05 Jan 2022 Preclinical trials in Gastrointestinal disorders in USA (Intradermal)
- 01 Dec 2021 Suono Bio has patent protection for Formulation-Independent Drug Delivery in USA